Comparing Cardiac Output Measurements Using a Wearable, Wireless, Non-invasive PPG-Based Device to a Swan Ganz Catheter
Sponsored by Biobeat Technologies Ltd.
About this trial
Last updated 3 years ago
Study ID
CO-002-00
Status
Completed
Type
Observational
Placebo
No
Accepting
18 to 120 Years
All
Not accepting
Healthy Volunteers
Trial Timing
Ended 3 years ago
What is this trial about?
Invasive pulmonary capillary wedge pressure measurements using a Swan-Ganz catheter (SGC)
is considered the gold standard for cardiac output (CO) monitoring. In this prospective
study, we will compare CO measurements between a PPG-based wearable monitor and a SGC in
ambulatory CHF patients.
What are the participation requirements?
Inclusion Criteria
- Patients with CHF
Exclusion Criteria
- Pregnant women
- Pediatric patients
- Inability to sign an informed consent form